<DOC>
	<DOCNO>NCT01081717</DOCNO>
	<brief_summary>The participant include observational study draw research database contain claim enrollment data member large , geographically diverse US health plan.The objective study estimate rate serious infection , tuberculosis , malignancy , outcome rheumatoid arthritis , psoriatic arthritis , ankylose spondylitis patient treat golimumab , anti-tumor necrosis factor ( TNF ) biologics , non-anti-TNF biologics , systemic non-biological treatment .</brief_summary>
	<brief_title>Golimumab Safety Surveillance Program Using Ingenix NHI Database</brief_title>
	<detailed_description>The participant include study drawn Ingenix Normative Health Informatics Database , proprietary research database contain claim enrollment data date back 1993 member large , geographically diverse US health plan . This study include cohort participant claim consistent diagnosis rheumatoid arthritis , psoriatic arthritis ankylose spondylitis initiate golimumab , anti-TNF biologics , non-anti-TNF biologics , systemic non-biological treatment . Participants identify claim bear code dispense drug , procedure diagnose follow launch golimumab 8 year . A sample enrol health plan member without claim evidence diagnosis treatment Rheumatoid arthritis , psoriatic arthritis ankylose spondylitis also select . The claim database use estimate incidence primary outcomes serious infection , tuberculosis ( TB ) non-TB mycobacterial infection , malignancy lymphoma , select outcome . No study agent administer study . All participant receive standard-of-care treatment prescribe physician</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Complete medical coverage pharmacy benefit Six month continuous enrollment prior date cohort entry Participants exclude information age , gender enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>psoriatic arthritis</keyword>
	<keyword>ankylose spondylitis</keyword>
	<keyword>golimumab</keyword>
	<keyword>anti-TNF biologics</keyword>
	<keyword>non-anti-TNF biologics</keyword>
	<keyword>non-biological treatment</keyword>
</DOC>